Efficacy and Safety of Ixekizumab in Patients with Refractory Guttate Psoriasis

NCT06374979 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Guttate Psoriasis

Interventions

BIOLOGICAL: Ixekizumab

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University